Mandatory notice of trades in IDEX – board remuneration in shares

IDEX ASA issues this notice on behalf of the primary insiders below. Following the annual general meeting of IDEX on 12 May 2017, board members Deborah Davis, Hanne Høvding and Andy MacLeod elected to receive part or full board remuneration in shares.

Board member Deborah Davis will acquire 47,404 shares for which she will pay a subscription price of NOK 0.15 per share, instead of receiving a cash board remuneration of NOK 300,000. After this transaction, Ms Davis will hold 95,891 shares and no other rights to shares in IDEX.

Board member Hanne Høvding will acquire 31,603 shares for which she will pay a subscription price of NOK 0.15 per share, instead of NOK 200,000 of the board remuneration. Ms Høvding will take the remainder of the board remuneration in cash. After this transaction, Ms Høvding will hold 397,665 shares and no other rights to shares in IDEX.

Board member Andrew James Macleod will acquire 36,343 shares for which he will pay a subscription price of NOK 0.15 per share, instead of NOK 230,000 of the board remuneration. Mr MacLeod will take the remainder of the board remuneration in cash. After this transaction, Mr MacLeod will hold 451,800 shares and 500,000 incentive subscription rights in IDEX.

Contact:
Charlotte Knudsen, Director of IR and Communications, +47 9756 1959, ck@idexbiometrics.com

About IDEX
IDEX develops and sells advanced fingerprint sensor technology and products. The company’s technology is used in a range of biometrically enabled applications within three core markets: Smartcards, mobile, and Internet of Things (IoT). IDEX’s addressable market represents a fast-growing multi-billion unit opportunity.

IDEX’s technology includes both the conventional silicon sensor and a unique off-chip technology, which means that the company can offer its partners solutions which are flexible and cost efficient.

IDEX ASA (ticker IDEX) is a Norwegian company, founded in 1996 and listed on the Oslo stock exchange in 2010.

For more information, please visit www.idexbiometrics.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

FACEBOOK
GOOGLE
TWITTER
LINKEDIN